Unique ID issued by UMIN | UMIN000040019 |
---|---|
Receipt number | R000045626 |
Scientific Title | Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancy |
Date of disclosure of the study information | 2020/04/14 |
Last modified on | 2020/04/24 14:16:20 |
Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancy
Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancy
Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancy
Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancy
Japan |
pulmonary malignancy
Chest surgery |
Malignancy
NO
To analyze the short- and long-term postoperative outcomes of robot-assisted surgery in respiratory surgery and to establish the utility and safety of robot-assisted surgery in respiratory surgery.
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Incidence of postoperative complications
Robotic surgery completion rate, intraoperative blood loss, operative time, length of hospital stay, medical costs, recurrence-free survival and overall survival
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
NO
NO
Institution is considered as a block.
NO
No need to know
1
Treatment
Device,equipment |
Robotic-assisted surgery is performed using the da Vinci Surgical System x, and the target procedure is "thoracoscopic pulmonary malignancy surgery (resection of the lung lobes or more than one lung lobe with endoscopic surgical support equipment). It is. The treatment and diagnostic policies and the extent of lymph node dissection for lung cancer are in accordance with the 2018 edition of the Lung Cancer Practice Guidelines.
20 | years-old | <= |
80 | years-old | >= |
Male and Female
PS (Performance Status) is 0 or 1.
No prior treatment for the disease.
Consent to participate in the study has been obtained in writing.
Diagnosis of pulmonary malignancy has been obtained by preoperative imaging or pathological examination.
In the case of primary lung malignancy, preoperative imaging indicates that the clinical stage of lung cancer is stage I-II.
In the case of metastatic pulmonary malignancy, no metastasis is observed in organs other than the lung.
PS (Performance Status) is 0 or 1.
No prior treatment for the disease.
Consent to participate in the study has been obtained in writing.
Diagnosis of pulmonary malignancy has been obtained by preoperative imaging or pathological examination.
In the case of primary lung malignancy, preoperative imaging indicates that the clinical stage of lung cancer is stage I-II.
In the case of metastatic pulmonary malignancy, no metastasis is observed in organs other than the lung.
20
1st name | HIDEKI |
Middle name | |
Last name | MATSUDAIRA |
The Jikei University School of Medicine
The Division of Thoracic Surgery, the Department of Surgery
105-8461
University Hall 2, 3-25-8, Nishi-Shimbashi, Minato-ku
0334331111
hideki.matsudaira@gmail.com
1st name | HIDEKI |
Middle name | |
Last name | MATSUDAIRA |
The Jikei University School of Medicine
The Division of Thoracic Surgery, the Department of Surgery
105-8461
University Hall 2, 3-25-8, Nishi-Shimbashi, Minato-ku
0334331111
hideki.matsudaira@gmail.com
he Division of Thoracic Surgery, the Department of Surgery, the Jikei University School of Medicine
The Division of Thoracic Surgery, the Department of Surgery, the Jikei University School of Medicine
Self funding
The Jikei University School of Medicine
3-25-8, Nishi-Shimbashi, Minato-ku
0334331111
rinri@jikei.ac.jp
NO
2020 | Year | 04 | Month | 14 | Day |
Unpublished
Enrolling by invitation
2020 | Year | 02 | Month | 03 | Day |
2020 | Year | 02 | Month | 03 | Day |
2020 | Year | 04 | Month | 14 | Day |
2025 | Year | 04 | Month | 14 | Day |
2020 | Year | 04 | Month | 01 | Day |
2020 | Year | 04 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045626